A French pharmaceutical company, Servier Laboratories, has been embroiled in a controversy over alleged falsification of documents to conceal adverse effects of its osteoporosis drug, Protelos.
The allegations were made in an article in the daily newspaper, Libération, on 6 September.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.